ALHC (Alignment Healthcare) Risk Assessment


ALHC Alignment Healthcare Inc ALHC
75 GF Score
Price $23.81
GF Value $19.21
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Alignment Healthcare Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Alignment Healthcare is: High Risk: High uncertainty with risk-return tradeoff.


Alignment Healthcare  (NAS:ALHC) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.


Alignment Healthcare Risk Assessment Related Terms


ALHC vs CLOV, PGNY, OSCR: Risk Assessment Comparison

For the Healthcare Plans subindustry, Alignment Healthcare's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alignment Healthcare Risk Assessment vs Healthcare Plans Industry

For the Healthcare Plans industry and Healthcare sector, Alignment Healthcare's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Alignment Healthcare's Risk Assessment falls into.


ALHC
75GF Score
Alignment Healthcare Inc ALHC
Risk Assessment is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Alignment Healthcare (ALHC) Overvalued in 2026?

Based on GuruFocus' analysis, Alignment Healthcare stock appears to be overvalued. The current stock price of $23.81 is trading 23.9% above its estimated GF Value™ of $19.21. GuruFocus considers Alignment Healthcare to be Modestly Overvalued.

Key valuation signals for ALHC:

  • Risk Assessment:
  • GF Value™: $19.21 vs. price of $23.81 (23.9% above fair value)
  • GF Score™: 75/100 with 5 warning signs

No single metric tells the full story. See the ALHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Alignment Healthcare Business Description

Address 1100 W. Town and Country Road, Suite 1600, Orange, CA, USA, 92868
Alignment Healthcare Inc is a next-generation, consumer-centric platform that is revolutionizing the healthcare experience for seniors through Medicare Advantage plans. These plans are marketed and sold direct-to-consumer, allowing seniors to select the manner in which customers receive healthcare coverage and services on an annual basis. The company combines a technology platform and clinical model for more effective health outcomes.
75GF Score

Get the complete analysis for ALHC

Risk Assessment is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$23.81
Price
$19.21
GF Value